butylscopolammonium bromide has been researched along with phenylhydrazine in 1 studies
| Studies (butylscopolammonium bromide) | Trials (butylscopolammonium bromide) | Recent Studies (post-2010) (butylscopolammonium bromide) | Studies (phenylhydrazine) | Trials (phenylhydrazine) | Recent Studies (post-2010) (phenylhydrazine) |
|---|---|---|---|---|---|
| 695 | 165 | 149 | 921 | 0 | 110 |
| Protein | Taxonomy | butylscopolammonium bromide (IC50) | phenylhydrazine (IC50) |
|---|---|---|---|
| Cytochrome P450 1A2 | Homo sapiens (human) | 8 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.9 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 3 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 6 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 1.666 | |
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | 0.5933 | |
| Indoleamine 2,3-dioxygenase 1 | Mus musculus (house mouse) | 0.2 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 5 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 1.514 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
1 other study(ies) available for butylscopolammonium bromide and phenylhydrazine
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |